J. B. Chemicals & Pharmaceuticals Limited (NSE:JBCHEPHARM)
India · Delayed Price · Currency is INR 1,659.50
-34.50 (-2.04%)
Aug 6, 2025, 3:29 PM IST
Splunk Revenue
J. B. Chemicals & Pharmaceuticals had revenue of 10.94B INR in the quarter ending June 30, 2025, with 8.91% growth. This brings the company's revenue in the last twelve months to 40.08B, up 11.56% year-over-year. In the fiscal year ending March 31, 2025, J. B. Chemicals & Pharmaceuticals had annual revenue of 39.18B with 12.45% growth.
Revenue (ttm)
40.08B
Revenue Growth
+11.56%
P/S Ratio
6.60
Revenue / Employee
7.56M
Employees
5,304
Market Cap
264.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 39.18B | 4.34B | 12.45% |
| Mar 31, 2024 | 34.84B | 3.35B | 10.63% |
| Mar 31, 2023 | 31.49B | 7.25B | 29.91% |
| Mar 31, 2022 | 24.24B | 3.82B | 18.69% |
| Mar 31, 2021 | 20.43B | 2.68B | 15.09% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 537.77B |
| Divi's Laboratories | 93.60B |
| Cipla | 274.80B |
| Mankind Pharma | 129.10B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Fortis Healthcare | 77.86B |
| Aurobindo Pharma | 317.24B |
J. B. Chemicals & Pharmaceuticals News
- 9 days ago - Top stocks to buy today: Stock recommendations for July 28, 2025 - check list - The Times of India
- 4 weeks ago - Torrent Pharmaceuticals to acquire additional 2.41% stake in JB Chemicals for Rs 620 crore - Business Upturn
- 5 weeks ago - Torrent set to be 5th largest pharma co - The Times of India
- 5 weeks ago - Torrent Pharma becomes India’s 5th largest drugmaker - The Times of India
- 5 weeks ago - Meta, KKR, Lululemon And An Industrial Stock On CNBC's 'Final Trades' - Benzinga
- 5 weeks ago - Torrent in Rs 18,000 crore deal, 2nd largest in pharma sector - The Times of India
- 5 weeks ago - India's Torrent to buy controlling stake in JB Chemicals from KKR for $1.4B - Seeking Alpha
- 5 weeks ago - Torrent Pharma revives talks to buy KKR stake in JB Chem - The Times of India